Later, Wegovy, a higher-dose version of semaglutide, was approved in 2021 specifically for weight management in individuals with obesity or those who are overweight with related health conditions.

As Ozempic keeps flying off the shelves, more and more people are taking the drug into their own hands by "microdosing" it.

Shares of Eli Lilly climbed Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo Nordisk.

The trial, known as SURMOUNT-5, found that participants using Zepbound lost an average of 20.2% of their body weight, while those on Wegovy lost 13.7%. This marks a 47% difference in weight loss ...

If you want to take Wegovy, a glucagon-like peptide-1 (GLP-1) receptor agonist medication for weight management, you might also be exploring telemedicine and the convenience of getting a ...

There's a terrifying new health trend among teenage boys, according to Men's Health's new documentary Generation Flex: Bulking up, even to the point of ignoring dangerous side effects. There's a ...

Catalent is an attractive buyout target for Novo Holdings — which owns 77% of the voting shares in the drugmaker — because it is currently a subcontractor that helps manufacture Wegovy ...